PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.71%
Negative revenue growth while 3141.T stands at 5.62%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-2.36%
Negative gross profit growth while 3141.T is at 6.63%. Joel Greenblatt would examine cost competitiveness or demand decline.
-17.14%
Negative EBIT growth while 3141.T is at 37.24%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-16.80%
Negative operating income growth while 3141.T is at 46.42%. Joel Greenblatt would press for urgent turnaround measures.
-17.89%
Negative net income growth while 3141.T stands at 65.20%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-17.88%
Negative EPS growth while 3141.T is at 65.17%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-17.88%
Negative diluted EPS growth while 3141.T is at 65.36%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Share reduction while 3141.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
27.78%
10Y revenue/share CAGR at 50-75% of 3141.T's 42.25%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
-5.26%
Negative 5Y CAGR while 3141.T stands at 41.67%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-31.58%
Negative 3Y CAGR while 3141.T stands at 22.91%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
No Data
No Data available this quarter, please select a different quarter.
99.93%
Below 50% of 3141.T's 315.59%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
12.21%
Below 50% of 3141.T's 102.18%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-34.86%
Negative 3Y CAGR while 3141.T is 1.71%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
94.36%
10Y equity/share CAGR at 75-90% of 3141.T's 109.52%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
32.39%
Below 50% of 3141.T's 102.12%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-14.03%
Negative 3Y equity/share growth while 3141.T is at 57.35%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.00%
Negative near-term dividend growth while 3141.T invests at 100.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
14.81%
Our AR growth while 3141.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
8.28%
We show growth while 3141.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
9.75%
Positive asset growth while 3141.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.09%
1.25-1.5x 3141.T's 3.28%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
113.93%
We have some new debt while 3141.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
2.04%
SG&A growth well above 3141.T's 2.20%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.